<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Oxford Technology 2 Venture Capital - Google Finance</title>
<description>News for Oxford Technology 2 Venture Capital - Google Finance</description>
<link>http://www.google.co.uk/finance?q=LON:OXH&amp;amp;client=news-rss&amp;amp;ei=4WWeUaicDrGr0AHq1AE</link>
<image>
<title>News for Oxford Technology 2 Venture Capital - Google Finance</title>
<url>/finance/s/-vLkpqn8pIU/images/logo_uk.gif</url>
<link>http://www.google.co.uk/finance?q=LON:OXH&amp;amp;client=news-rss&amp;amp;ei=4WWeUaicDrGr0AHq1AE</link>
</image>
<item>
<title>Debunking Myths About Biotech Venture Capital</title>
<link>http://www.forbes.com/sites/brucebooth/2013/05/22/debunking-myths-about-biotech-venture-capital/</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:http://www.forbes.com/sites/brucebooth/2013/05/22/debunking-myths-about-biotech-venture-capital/</guid>
<pubDate>Wed, 22 May 2013 13:50:34 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.forbes.com/sites/brucebooth/2013/05/22/debunking-myths-about-biotech-venture-capital/&quot; style=&quot;font-size:1.2em&quot;&gt;Debunking Myths About Biotech Venture Capital&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Forbes&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 22, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Further, they significantly bias against Life Sciences due to the “unrealized return problem” (discussed here by Bijan); “Tech unrealized IRR overstates actual tech venture realized returns and Healthcare unrealized IRR understates it. ... only the top ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Gazprom Finds Little Reason to Celebrate on its 20th Birthday</title>
<link>http://oilprice.com/Energy/Natural-Gas/Gazprom-Finds-Little-Reason-to-Celebrate-on-its-20th-Birthday.html</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:http://oilprice.com/Energy/Natural-Gas/Gazprom-Finds-Little-Reason-to-Celebrate-on-its-20th-Birthday.html</guid>
<pubDate>Wed, 22 May 2013 00:24:56 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://oilprice.com/Energy/Natural-Gas/Gazprom-Finds-Little-Reason-to-Celebrate-on-its-20th-Birthday.html&quot; style=&quot;font-size:1.2em&quot;&gt;Gazprom Finds Little Reason to Celebrate on its 20th Birthday&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;OilPrice.com&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 22, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Ildar Davletshin, an oil and gas analyst at Renaissance Capital, says that despite the changing market Gazprom continued to insist on costly long-term gas contracts pegged to the price of oil.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Green Energy Waste Is Spoiling The Bunch</title>
<link>http://seekingalpha.com/article/1453431-green-energy-waste-is-spoiling-the-bunch?source=google_news</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:http://seekingalpha.com/article/1453431-green-energy-waste-is-spoiling-the-bunch?source=google_news</guid>
<pubDate>Wed, 22 May 2013 15:40:38 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://seekingalpha.com/article/1453431-green-energy-waste-is-spoiling-the-bunch?source=google_news&quot; style=&quot;font-size:1.2em&quot;&gt;Green Energy Waste Is Spoiling The Bunch&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Seeking Alpha&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 22, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Neither went anywhere, and common sense solutions like the Fischer-Tropsch process that can turn carbon based materials into fuel were ignored, even though it was proven technology and firms had been using it since the 1920s. Unfortunately the central ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>CAE Management Discusses Q4 2013 Results - Earnings Call Transcript</title>
<link>http://seekingalpha.com/article/1442041-cae-management-discusses-q4-2013-results-earnings-call-transcript</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:http://seekingalpha.com/article/1442041-cae-management-discusses-q4-2013-results-earnings-call-transcript</guid>
<pubDate>Thu, 16 May 2013 23:01:35 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://seekingalpha.com/article/1442041-cae-management-discusses-q4-2013-results-earnings-call-transcript&quot; style=&quot;font-size:1.2em&quot;&gt;CAE Management Discusses Q4 2013 Results - Earnings Call Transcript&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Seeking Alpha&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 16, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;We developed new products in both Healthcare and Mining to expand our portfolio, and we&amp;#39;ve begun to see some synergies with our core Military and Civil businesses in terms of technology and market reach. During the quarter, in ... The additional ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>ProfNet Roundup: 2013 Commencement Speakers</title>
<link>http://online.wsj.com/article/PR-CO-20130508-916944.html?mod=googlenews_wsj</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:52778147043933</guid>
<pubDate>Wed, 08 May 2013 21:39:47 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://online.wsj.com/article/PR-CO-20130508-916944.html?mod=googlenews_wsj&quot; style=&quot;font-size:1.2em&quot;&gt;ProfNet Roundup: 2013 Commencement Speakers&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Wall Street Journal (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 8, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Honorary degrees: 1) James Sandman, president of the Legal Services Corp., headquartered in Washington; 2) J. Spencer and Patricia Hunter Standish, philanthropists.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>4 lessons from a failed IBM-Roche collaboration</title>
<link>http://money.msn.com/top-stocks/post.aspx?post=d14b909a-d869-45e6-b590-ae3944c06895</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:52778128979802</guid>
<pubDate>Tue, 23 Apr 2013 19:11:46 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://money.msn.com/top-stocks/post.aspx?post=d14b909a-d869-45e6-b590-ae3944c06895&quot; style=&quot;font-size:1.2em&quot;&gt;4 lessons from a failed IBM-Roche collaboration&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;MSN Money&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 23, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;By Forbes Digital Apr 23, 2013 2:57PM. Scientists monitoring computers in ... All of these technologies could make DNA sequencing cheaper, faster, easier and more portable -- Oxford Nanopore has shown off mock-ups of DNA sequencers that are literally ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Who do you trust in social enterprise?</title>
<link>http://www.guardian.co.uk/social-enterprise-network/2013/apr/26/trust-social-enterprise</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:http://www.guardian.co.uk/social-enterprise-network/2013/apr/26/trust-social-enterprise</guid>
<pubDate>Fri, 26 Apr 2013 06:23:34 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.guardian.co.uk/social-enterprise-network/2013/apr/26/trust-social-enterprise&quot; style=&quot;font-size:1.2em&quot;&gt;Who do you trust in social enterprise?&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;The Guardian&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 26, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;&amp;#39;By going with the normal flow of free-market enterprise and the emerging replacement of monetary capital with intellectual capital as the dominant form of basic enterprise capitalization, it becomes easier to set up new companies primarily on the ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Market outlook: Effective delivery of capital projects</title>
<link>http://www.icis.com/Articles/2013/04/26/9662822/market-outlook-effective-delivery-of-capital-projects.html</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:52778133361553</guid>
<pubDate>Fri, 26 Apr 2013 15:26:48 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.icis.com/Articles/2013/04/26/9662822/market-outlook-effective-delivery-of-capital-projects.html&quot; style=&quot;font-size:1.2em&quot;&gt;Market outlook: Effective delivery of capital projects&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;ICIS (subscription)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 26, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;In developed regions, the workforce is aging and the industry has had difficulty competing with high-tech companies, like Google, eBay and Amazon, for top college graduates.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>EPO Pills: A Challenge For Amgen And Johnson &amp;amp; Johnson</title>
<link>http://seekingalpha.com/article/1394161-epo-pills-a-challenge-for-amgen-and-johnson-johnson?source=google_news</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:http://seekingalpha.com/article/1394161-epo-pills-a-challenge-for-amgen-and-johnson-johnson?source=google_news</guid>
<pubDate>Thu, 02 May 2013 16:36:35 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://seekingalpha.com/article/1394161-epo-pills-a-challenge-for-amgen-and-johnson-johnson?source=google_news&quot; style=&quot;font-size:1.2em&quot;&gt;EPO Pills: A Challenge For Amgen And Johnson &amp;amp; Johnson&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Seeking Alpha&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 2, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;EPO pills are a new technology currently in development. Their mechanism of action is entirely ... In Phase 2 the drug has been able to correct and maintain hemoglobin levels in newly treated CKD patients not yet receiving dialysis and in patients with ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>TransAlta&amp;#39;s CEO Hosts Annual Meeting of Shareholders Conference (Transcript)</title>
<link>http://seekingalpha.com/article/1364371-transalta-s-ceo-hosts-annual-meeting-of-shareholders-conference-transcript?source=google_news</link>
<guid isPermaLink="false">tag:finance.google.co.uk,cluster:52778131021144</guid>
<pubDate>Wed, 24 Apr 2013 02:53:46 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://seekingalpha.com/article/1364371-transalta-s-ceo-hosts-annual-meeting-of-shareholders-conference-transcript?source=google_news&quot; style=&quot;font-size:1.2em&quot;&gt;TransAlta&amp;#39;s CEO Hosts Annual Meeting of Shareholders Conference (Transcript)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Seeking Alpha&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 24, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Tim is a resident of Oxford, England and has been a director since 2003. He is a veteran of Royal ..... Now, as we entered 2012, we face two main pressures in our company, falling prices in the Pacific Northwest and the hangover on the Sundance 1 and 2 ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
